Overall rank by patents
#12,403
Across all tracked assignees
USPTO PatentsView assignee record - 24 granted patents across 12 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: D21H (PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERW).
The verdict
Delfortgroup holds 24 US patents across 12 technology areas, rank #12,403 of 50,000 tracked assignees.
Delfortgroup Ag has been granted 24 US utility patents between 2015 and 2025, placing Delfortgroup Ag at rank #12,403 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.4 claims per patent with primary concentration in D21H (PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERW). As a Foreign Corporation, Delfortgroup Ag is one of the more focused assignees in the PatentsView dataset. By volume, Delfortgroup sits between Cyclerion Therapeutics, Inc. (24 patents, rank #12,399) and Digitalinsights Inc. (24 patents, rank #12,407) - the closest US assignees by grant volume. The composite Innovation Score of 40.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 17 in the 2015–2019 window, a -59% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Delfortgroup Ag's 25.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Delfortgroup Ag against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cyclerion Therapeutics, Inc.
24 patents
Cyral Inc.
24 patents
D-Link Corporation
24 patents
DEKA BIOSCIENCES, INC.
24 patents
DENKA SEIKEN CO., LTD.
24 patents
DENTSU INC.
24 patents
DIGITAL SURGERY LIMITED
24 patents
DIGITALINSIGHTS INC.
24 patents
DELFORTGROUP AG
24 patents
What this shows Delfortgroup holds 24 patents at rank #12,403, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #12,403 in granted patent volume.
Other assignees with the most granted patents in Delfortgroup's primary technology class.
Delfortgroup's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 8.3% |
| 2016 | 6 | 25.0% |
| 2017 | 2 | 8.3% |
| 2018 | 1 | 4.2% |
| 2019 | 6 | 25.0% |
| 2020 | 1 | 4.2% |
| 2021 | 1 | 4.2% |
| 2022 | 1 | 4.2% |
| 2024 | 2 | 8.3% |
| 2025 | 2 | 8.3% |
Top 12 of 12 technology areas
Overall rank by patents
#12,403
Across all tracked assignees
40.9 out of 100
How to use this portfolio
Delfortgroup's 24 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.